Predictive Model for Permanent Shunting in Cryptococcal meningitis.

Cryptococcal meningitis may have long-term morbidity and requires a permanent cerebrospinal fluid shunt. This study aimed to evaluate the risk factors and create a predictive model for permanent shunt treatment in cryptococcal meningitis patients. This was a retrospective analytical study conducted at Khon Kaen University. The study period was from January 2005 to December 2015. We enrolled all adult patients diagnosed with cryptococcal meningitis. Risk factors predictive for permanent shunting treatment were analyzed by multivariate logistic regression analysis. There were 341 patients diagnosed with cryptococcal meningitis. Of those, 64 patients (18.7%) were treated with permanent shunts. There were three independent factors associated with permanent shunt treatment. The presence of hydrocephalus had the highest adjusted odds ratio at 56.77. The resulting predictive model for permanent shunt treatment (y) is (-3.85) + (4.04 × hydrocephalus) + (2.13 × initial cerebrospinal fluid (CSF) opening pressure (OP) > 25 cm H2O) + (1.87 × non-human immune deficiency vrus (HIV)). In conclusion, non-HIV status, initial CSF OP greater than or equal to 25 cm H2O, and the presence of hydrocephalus are indicators of the future necessity for permanent shunt therapy.

[1]  S. Gopinath,et al.  Shunting in cryptococcal meningitis. , 2016, Journal of neurosurgery.

[2]  Y.-M. Wang,et al.  Clinical study of 23 pediatric patients with cryptococcosis. , 2015, European review for medical and pharmacological sciences.

[3]  Hui Wang,et al.  Evaluation of ventriculoperitoneal shunt in the treatment of intracranial hypertension in the patients with cryptococcal meningitis: A report of 12 cases , 2014, Clinical Neurology and Neurosurgery.

[4]  P. Pappas Cryptococcal infections in non-HIV-infected patients. , 2013, Transactions of the American Clinical and Climatological Association.

[5]  S. Moscovici,et al.  Ventriculoperitoneal shunt for intracranial hypertension in cryptococcal meningitis without hydrocephalus , 2012, Journal of Clinical Neuroscience.

[6]  A. Dinçer,et al.  Radiologic evaluation of pediatric hydrocephalus , 2011, Child's Nervous System.

[7]  J. Perfect,et al.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Jaffar,et al.  Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures , 2009, AIDS.

[9]  E. Mylonakis,et al.  Epidemiology and management of cryptococcal meningitis: developments and challenges , 2008, Expert opinion on pharmacotherapy.

[10]  M. McGirt,et al.  The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis. , 2005, Surgical neurology.

[11]  Cheng-Hsien Lu,et al.  Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  I. Pople,et al.  HYDROCEPHALUS AND SHUNTS: WHAT THE NEUROLOGIST SHOULD KNOW , 2002, Journal of neurology, neurosurgery, and psychiatry.

[13]  D. Denning,et al.  Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. , 1991, The American journal of medicine.

[14]  P. Richardson,et al.  Cerebral cryptococcosis in Malaysia. , 1976, Journal of neurology, neurosurgery, and psychiatry.